Hofseth BioCare ASA Statistics
Total Valuation
Hofseth BioCare ASA has a market cap or net worth of NOK 830.38 million. The enterprise value is 981.92 million.
Market Cap | 830.38M |
Enterprise Value | 981.92M |
Important Dates
The last earnings date was Thursday, August 29, 2024.
Earnings Date | Aug 29, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Hofseth BioCare ASA has 411.08 million shares outstanding. The number of shares has increased by 2.43% in one year.
Shares Outstanding | 411.08M |
Shares Change (YoY) | +2.43% |
Shares Change (QoQ) | +0.17% |
Owned by Insiders (%) | 18.62% |
Owned by Institutions (%) | 35.91% |
Float | 197.03M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 3.54 |
PB Ratio | 6.01 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -8.10 |
EV / Sales | 4.27 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -37.20 |
Financial Position
The company has a current ratio of 0.87, with a Debt / Equity ratio of 129.06.
Current Ratio | 0.87 |
Quick Ratio | 0.34 |
Debt / Equity | 129.06 |
Debt / EBITDA | n/a |
Debt / FCF | -6.73 |
Interest Coverage | -11.71 |
Financial Efficiency
Return on equity (ROE) is -95.34% and return on invested capital (ROIC) is -26.31%.
Return on Equity (ROE) | -95.34% |
Return on Assets (ROA) | -17.61% |
Return on Capital (ROIC) | -26.31% |
Revenue Per Employee | 3.29M |
Profits Per Employee | -1.73M |
Employee Count | 71 |
Asset Turnover | 0.58 |
Inventory Turnover | 1.88 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -35.87% in the last 52 weeks. The beta is 0.37, so Hofseth BioCare ASA's price volatility has been lower than the market average.
Beta (5Y) | 0.37 |
52-Week Price Change | -35.87% |
50-Day Moving Average | 2.05 |
200-Day Moving Average | 2.28 |
Relative Strength Index (RSI) | 47.97 |
Average Volume (20 Days) | 78,594 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Hofseth BioCare ASA had revenue of NOK 230.08 million and -121.18 million in losses. Loss per share was -0.30.
Revenue | 230.08M |
Gross Profit | 58.51M |
Operating Income | -112.22M |
Pretax Income | -121.18M |
Net Income | -121.18M |
EBITDA | -97.86M |
EBIT | -112.22M |
Loss Per Share | -0.30 |
Balance Sheet
The company has 25.30 million in cash and 177.52 million in debt, giving a net cash position of -152.22 million or -0.37 per share.
Cash & Cash Equivalents | 25.30M |
Total Debt | 177.52M |
Net Cash | -152.22M |
Net Cash Per Share | -0.37 |
Equity (Book Value) | 137.55M |
Book Value Per Share | 0.34 |
Working Capital | -19.70M |
Cash Flow
In the last 12 months, operating cash flow was -19.24 million and capital expenditures -7.16 million, giving a free cash flow of -26.39 million.
Operating Cash Flow | -19.24M |
Capital Expenditures | -7.16M |
Free Cash Flow | -26.39M |
FCF Per Share | -0.06 |
Margins
Gross margin is 25.43%, with operating and profit margins of -48.77% and -52.67%.
Gross Margin | 25.43% |
Operating Margin | -48.77% |
Pretax Margin | -52.67% |
Profit Margin | -52.67% |
EBITDA Margin | -42.53% |
EBIT Margin | -48.77% |
FCF Margin | -11.47% |
Dividends & Yields
Hofseth BioCare ASA does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -2.43% |
Shareholder Yield | -2.43% |
Earnings Yield | -14.89% |
FCF Yield | -3.18% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |